BOCA RATON, Fla. – ADT’s refocus on its core consumer security and smart home business has paid off, with a strong start to 2024, company officials said. The company reported total revenue of $1.2 ...

ADT reports that its cybersecurity systems were breached this week. The company says personal information of customers and prospective customers was accessed. ADT says everyone who was affected has ...

ADT, one of the UK’s most established and trusted home security providers, is proud to announce a new partnership with Arsenal, becoming the club’s Official Community Security Partner. The multi-year ...

First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors MEDLINE (1966-2018), Embase (1982-2018), ...

Shares of ADT were lower after the company logged lower a fourth-quarter profit and said it expects profit and revenue to be flat for the year. The stock slipped 5.4%, to $7.59, in premarket trading ...

Tyler has worked on, lived with and tested all types of smart home and security technology for over a dozen years, explaining the latest features, privacy tricks, and top recommendations. With degrees ...

The company will use Origin Wireless’ AI sensing to expand the capabilities of its smart home security products. The company will use Origin Wireless’ AI sensing to expand the capabilities of its ...

ADT is a defensive, cash-generative business trading below intrinsic value, assuming it increases its ROIC. State Farm and Apollo, holding ~27% combined, may sell shares, potentially pressuring ADT’s ...

Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Androgen deprivation therapy (ADT), also called hormone therapy, is a common treatment for metastatic prostate cancer. It works by starving the cancer of testosterone, which fuels the tumor’s growth.

ADT remains undervalued versus newly listed peer Verisure, supported by strong revenue growth, improving profitability, and a high share of recurring revenue. ADT's business is supported by ...